From the Invention of the Stethoscope in 1860 technology has revolutionized modern medicine.
Today Heamodalisis machines can purify blood,Ultrasound machines diagnose cancers and check up on the wellbeing of unborn infants and microprocessor controlled robots can conduct micro surgical operations.
Sadly however the introduction of medical technology has not been so rapid in developing countries.
In fact 90% of global healthcare spending is spent on 10% of the worlds population who live in the developing world.
In contrast 90 percent of the worlds burden of life threatening illnesses is born by those living in developing countries which account for only 10% of global healthcare spending.
Medicine Mondiale's mission is to bridge the gap in the delivery of affordable high quality healthcare on a global scale.
We believe this is technically possible and commercially feasible.
The reality is there are plenty of "customers" in developing countries but the cost of modern medical treatment is often outside their reach.
Our solution is to reduce the cost of quality medical interventions.
It can be done.
In the early eighties the WHO recommended surgical procedure for treating cataract blind patients in developing countries was to remove the degenerated "milky" lens of the eye and provide the patient with a set of Aphakic "glasses which cost $25 with the complete operation costing US$125.
This operation resulted is such poor vision that the patient was still classified as clinically blind.
In contrast the standard treatment for Cataract surgery in the US at this time was to remove the "milky" lenses and replace it with a permanently implanted plastic lens costing US $300 or more,with the complete operation costing about US $3000.
This operation resulted in patients with perfect 20 20 vision.
In the early nineties Medicine Mondiale technologists invented and developed a revolutionary process for making high quality CE mark approved low cost Intraocular lenses for as little as US $7 each, while the Fred Hollows Foundation and it's partner organizations brought down the cost of conducting modern ICCE + IOL implantation cataract surgery to just US$25 in the developing world.
This made modern cataract surgery accessible to the poorest of the poor in the developing world and revolutionized the treatment of cataract blindness on a global scale.
Today the WHO recommended treatment for Cataract Blindness in the developing world is ICCE + IOL implantation which is the same treatment a cataract patient receives in the US.
Our belief is that we can apply this principle to other medical problems endemic in the developing world.
Our medical technologies are state of the art first world technologies which have a footprint in both developed world and developing world markets.
We believe that just because you are born in a developing country you should not be relegated to receiving third rate medical care.
We are committed to making quality healthcare accessible to all.